Chaokun Yan 1 , Luping Feng 1 , Wenxiu Wang 1 , Jianlin Wang 1 , Ge Zhang 1 , Junwei Luo 2 . Show Affiliations »
Abstract
BACKGROUND: Drug repositioning refers to discovering new indications for the existing drugs, which can improve the efficiency of drug research and development. METHODS: In this work, a novel drug repositioning approach based on integrative multiple similarity measure, called DR_IMSM, is proposed. The process of integrative similarity measure contains three steps. First, a heterogeneous network can be constructed based on known drug-disease association, shared entities information for drug pairwise and diseases pairwise. Second, a deep learning method, DeepWalk, is used to capture the topology similarity for drug and disease. Third, a similarity integration and adjusting process is further conducted to obtain more comprehensive drug and disease similarity measure, respectively. RESULTS: On this basis, a Bi-random walk algorithm is implemented in the constructed heterogeneous network to rank diseases for each drug. Compared with other approaches, the proposed DR_IMSM can achieve superior performance in terms of AUC on the gold standard datasets. Case studies further confirm the practical significance of DR_IMSM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
BACKGROUND: Drug repositioning refers to discovering new indications for the existing drugs, which can improve the efficiency of drug research and development. METHODS: In this work, a novel drug repositioning approach based on integrative multiple similarity measure, called DR_IMSM, is proposed. The process of integrative similarity measure contains three steps. First, a heterogeneous network can be constructed based on known drug-disease association, shared entities information for drug pairwise and diseases pairwise. Second, a deep learning method, DeepWalk, is used to capture the topology similarity for drug and disease . Third, a similarity integration and adjusting process is further conducted to obtain more comprehensive drug and disease similarity measure, respectively. RESULTS: On this basis, a Bi -random walk algorithm is implemented in the constructed heterogeneous network to rank diseases for each drug. Compared with other approaches, the proposed DR_IMSM can achieve superior performance in terms of AUC on the gold standard datasets. Case studies further confirm the practical significance of DR_IMSM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Entities: Chemical
Disease
Keywords:
Drug repositioning; bi-randomzzm321990walk; deepwalk; heterogeneous network; logistic function; similarity measure.
Mesh: See more »
Year: 2020
PMID: 31729291 DOI: 10.2174/1566524019666191115103307
Source DB: PubMed Journal: Curr Mol Med ISSN: 1566-5240 Impact factor: 2.222